Recursion Pharmaceuticals Inc (RXRX)
8.26
-0.61
(-6.88%)
USD |
NASDAQ |
May 31, 16:00
8.36
+0.10
(+1.21%)
After-Hours: 20:00
Recursion Pharmaceuticals Gross Profit (Quarterly): 2.325M for March 31, 2024
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 2.325M |
| December 31, 2023 | 0.743M |
| September 30, 2023 | -0.775M |
| June 30, 2023 | 1.634M |
| March 31, 2023 | -0.314M |
| December 31, 2022 | 2.836M |
| September 30, 2022 | -2.356M |
| Date | Value |
|---|---|
| June 30, 2022 | -6.574M |
| March 31, 2022 | -2.50M |
| December 31, 2021 | 2.50M |
| September 30, 2021 | 2.50M |
| June 30, 2021 | 2.50M |
| March 31, 2021 | 2.50M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
-6.574M
Minimum
Jun 2022
2.836M
Maximum
Dec 2022
0.3861M
Average
1.634M
Median
Jun 2023
Gross Profit (Quarterly) Benchmarks
| Eli Lilly and Co | 7.094B |
| Viking Therapeutics Inc | -- |
| Actinium Pharmaceuticals Inc | -- |
| Macrogenics Inc | 6.988M |
| Marinus Pharmaceuticals Inc | 6.923M |